In addition, earlier studies have shown that CD4+ T cells in SLE have mitochondrial abnormalities, including increased mitochondrial size and membrane disruption, and led us to look for altered mitochondrial status and the ROS levels of SLE CD8+ T cells. The gene discussed is CD8A; the disease is systemic lupus erythematosus.